Epilepsies, White Matter Alterations
Conditions
Keywords
Children, epilepsy, white matter, hyperintensity
Brief summary
Aim: Neuroimaging is an important tool, in combination with a detailed medical history, physical examination, and electroencephalography, in the diagnosis and classification of epilepsy. White matter hyperintensities (WMHs) are bright areas of high signal intensity seen in white matter at T2-weighted MRI. Researchers aimed to evaluate whether white matter hyperintensities are more common in children with epilepsy. Material-method: Patients who underwent cranial MRI with diagnoses of epilepsy based on International League Against Epilepsy (ILAE) criteria at the Balıkesir University Medical Faculty Pediatric neurology clinic, Türkiye, between 01.08.2019 and 01.03.2024 and patients who underwent cranial MRI during the same period due to indications other than epilepsy, such as headache, syncope, and vertigo, were included in the study. Written informed consent was received from all patients.
Detailed description
Aim: Neuroimaging is an important tool, in combination with a detailed medical history, physical examination, and electroencephalography, in the diagnosis and classification of epilepsy. White matter hyperintensities (WMHs) are bright areas of high signal intensity seen in white matter at T2-weighted MRI. Researchers aimed to evaluate whether white matter hyperintensities are more common in children with epilepsy. Material-method: Patients who underwent cranial MRI with diagnoses of epilepsy based on International League Against Epilepsy (ILAE) criteria at the Balıkesir University Medical Faculty Pediatric neurology clinic, Türkiye, between 01.08.2019 and 01.03.2024 and patients who underwent cranial MRI during the same period due to indications other than epilepsy, such as headache, syncope, and vertigo, were included in the study. Written informed consent was received from all patients.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
Cranial MRI during the same period due to indications other than epilepsy; * headache * syncope and * vertigo
Exclusion criteria
Patients with neuropsychiatric disorders; * depression, * psychotic disorders, * autism spectrum disorder History of medication use for any chronic disease other than seizure medication, History of vascular disease ; * Collagen tissue diseases; * lupus, * juvenile rheumatoid arthritis, * polyarteritis nodosa, * Kawasaki disease Demyelinating disease * acute demyelinating disease (ADEM), * Multiple sclerosis Acute symptomatic seizure or a single unprovoked seizure, İncomplete file data, or MRI performed at a location other than our hospital
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The Evaluation of White Matter Intensities in Patients with Pediatric Epilepsy | 01.08.2019 and 01.03.2024 | To determine whether white matter hyperintensities are more frequent in children with epilepsy by comparing epilepsy and control groups. |
Countries
Turkey (Türkiye)